th of your group.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
href= "http://www.ekearneyalliance.com">www.ekearneyalliance.com This team has an em
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
phasis on business management and therefore everyone posted is in that arena as well. Res
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
erving a dot com is not all that expensive. Putting up the website may take a little more
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
time and money unless someone on your team volunteers to put it up. You will need to make
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
sure that contact information for each person is available.
Each partner sho
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
uld have equal billing on the website but there should also be only one central number to
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
call. If you are doing a lot of business this way, I would suggest getting a separate pho
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ne line that can be answered with the name of the group. This will give you a "brand". We
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
will talk about branding a little later. Selecting the location of the phone line is ent
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
rely up to the group and it should not make any difference who it is as long as it is a g
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
roup expense.
When working in the team environment, you will be doing many thi
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ngs together that relate to projects. The team, however, needs to operate beyond just doi
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
g business. There are many marketing and public relation activities that should be examin
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ed to further the amount of business. Once such thing is to collaborate on writing a book
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products